Prostaglandin E2 suppresses polyinosine - Polycytidylic acid (polyI:C)-stimulated cytokine production via prostaglandin E2 receptor (EP) 2 and 3 in human conjunctival epithelial cells

British Journal of Ophthalmology

Volumn 95, Issue 6, 2011, Pages 859-863

  Ueta, Mayumi ^a,b   Matsuoka, Toshiyuki ^c   Yokoi, Norihiko ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

^c HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 2 AGONIST; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 3 AGONIST; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RANTES; UNCLASSIFIED DRUG; CYCLIC AMP; CYTOKINE;

ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; LIGAND BINDING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CONJUNCTIVA; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM;

CONJUNCTIVA; CYCLIC AMP; CYTOKINES; DINOPROSTONE; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; POLY I-C; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79956353740     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.199679     Document Type: Article

References (19)

1. Matsuoka T, Narumiya S. Prostaglandin receptor signaling in disease. Scientific World Journal 2007;7:1329-47. (Pubitemid 47435437)
2. Takayama K, Garcia-Cardena G, Sukhova GK, et al. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002;277:44147-54. (Pubitemid 36157844)
3. Xu XJ, Reichner JS, Mastrofrancesco B, et al. Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production. J Immunol 2008;180:2125-31.
4. Shiraishi H, Yoshida H, Saeki K, et al. Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells. Int Immunol 2008;20:1219-29.
5. Ueta M, Hamuro J, Kiyono H, et al. Triggering of TLR3 by polyI: C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun 2005;331:285-94. (Pubitemid 40545174)
6. Ueta M, Kinoshita S. Innate immunity of the ocular surface. Brain Res Bull 2010;81:219-28.
7. Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-8. (Pubitemid 33009951)
8. Ueta M, Kinoshita S. Ocular surface inflammation mediated by innate immunity. Eye Contact Lens 2010;36:269-81.
9. Ueta M, Mizushima K, Yokoi N, et al. Gene-expression analysis of polyI: C-stimulated primary human conjunctival epithelial cells. Br J Ophthalmol 2010;94:1528-32.
10. Kumar A, Zhang J, Yu FS. Toll-like receptor 3 agonist poly(I: C)-induced antiviral response in human corneal epithelial cells. Immunology 2006;117:11-21.
11. Li J, Shen J, Beuerman RW. Expression of toll-like receptors in human limbal and conjunctival epithelial cells. Mol Vis 2007;13:813-22. (Pubitemid 46902153)
12. Ueta M, Kawai T, Yokoi N, et al. Contribution of IPS-1 to polyI: C-induced cytokine production in conjunctival epithelial cells. Biochem Biophys Res Commun 2011;404:419-23.
13. Ueta M, Mizushima K, Yokoi N, et al. Expression of the interleukin-4 receptor alpha in human conjunctival epithelial cells. Br J Ophthalmol 2010;94:1239-43.
14. Kojima K, Ueta M, Hamuro J, et al. Human conjunctival epithelial cells express functional Toll-like receptor 5. Br J Ophthalmol 2008;92:411-16. (Pubitemid 351363541)
15. Ueta M, Sotozono C, Nakano M, et al. Association between prostaglandin E receptor 3 polymorphisms and Stevens - Johnson syndrome identified by means of a genome-wide association study. J Allergy Clin Immunol 2010;126:1218-25.e10.
16. Suzawa T, Miyaura C, Inada M, et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 2000;141:1554-9. (Pubitemid 32269125)
17. Ueta M, Matsuoka T, Narumiya S, et al. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol 2009;123:466-71.
18. Ueta M, Matsuoka T, Yokoi N, et al. Prostaglandin E receptor subtype EP3 downregulates TSLP expression in human conjunctival epithelium. Br J Ophthalmol. Published Online First: 29 September 2010. doi:10.1136/bjo.2010.188748.
19. Ueta M, Sotozono C, Yokoi N, et al. Prostaglandin E receptor 4 expression in human conjunctival epithelium and its downregulation in devastating ocular surface inflammatory disorders. Arch Ophthalmol 2010;128:1369-71.